@article{3b333ce769454b0d926aea3d132c2088,
title = "European Medicines Agency must take account of cardiovascular harm associated with degludec insulin",
keywords = "Cardiovascular Diseases, Diabetes Mellitus, Type 2, Drug Approval, Europe, European Union, Female, Government Agencies, Humans, Hypoglycemic Agents, Insulin, Long-Acting, Male, Product Surveillance, Postmarketing, Public Health, United States, United States Food and Drug Administration",
author = "Schmidt, {Thomas A} and Rosen, {Clifford J} and Yudkin, {John S}",
year = "2013",
month = jun,
day = "20",
doi = "10.1136/bmj.f3731",
language = "English",
volume = "346",
pages = "f3731",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
}
